REGENERON PHARMACEUTICALS INC
- Unique Entity ID (UEI)
- N3F9MH7E6HD6
- Parent company
- REGENERON PHARMACEUTICALS INC (this vendor is its own parent)
- Registered address
- TARRYTOWN, NY, district NY-17
- Other names on record
- REGENERON PHARMACEUTICALS, INC.
Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.
Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved November 19, 2026.
Which agencies pay this vendor, and where the work is done
Fiscal year 2027
USAspending lists no contract dollars for this vendor in fiscal year 2027 yet.
Fiscal year 2026: $279,399,579.88
| Agency | Contract dollars |
|---|---|
| Department of Health and Human Services | $279,399,579.88 |
| District where the work is done | Contract dollars |
|---|---|
| NY-17Michael Lawler | $279,399,579.88 |
Largest awards
The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.
| Award | Agency | Where the work is done | Award total | Start |
|---|---|---|---|---|
| HHSO100201700016CIGF::OT::IGF | Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | TARRYTOWN, NY-17 | $973,560,406.91 | Ends September 29, 2031 |
| HHSO100201700020CIGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | TARRYTOWN, NY-17 | $278,844,171.83 | Ends September 25, 2027 |
| HHSO100201600023CIGF::OT::IGF | Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | TARRYTOWN, NY-17 | $8,601,628.71 | Ends September 30, 2022 |
Subcontracts it reported
A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.
Under award HHSO100201700016C
| Subcontractor | What it is for, as reported | Amount | Date |
|---|---|---|---|
| CATALENT INDIANA LLC | DP FILLS - EB3 C2 | $3,288,941.45 | |
| CATALENT INDIANA LLC | DP FILL EB3 | $2,752,500 | |
| TEXAS BIOMEDICAL RESEARCH INSTITUTE | RHESUS PK STUDY | $1,844,948 | |
| FISHER CLINICAL SERVICES INC | CLINICAL LABELING | $615,701.06 | |
| LA JOLLA INSTITUTE FOR IMMUNOLOGY | EB3 EPITOPE MAPPING | $601,744 | |
| DELTAMED SOLUTIONS INC | STATISTICAL SUPPORT EB3 | $463,910 | |
| COVANCE BIOANALYTICAL SERVICES, LLC | A SINGLE DOSE PHARMACOKINETIC STUDY FOLLOWING INTRAVENOUS ADMINISTRATION TO RHESUS MONKEYS | $310,534 | |
| TEXAS BIOMEDICAL RESEARCH INSTITUTE | AMENDMENT TO RHESUS PK STUDY | $289,019 | |
| CATALENT INDIANA LLC | WATER FILL RUN | $270,000 | |
| CATALENT INDIANA LLC | INTERIM STERILITY VALIDATION REPORT - | $247,378.60 |
More subcontracts are reported under this award; the 10 largest are listed.
Lobbying reports and campaign receipts that name this vendor
No lobbying report, organization page or FEC receipt in our saved records has this vendor’s name or its parent company’s name.
A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.